收藏切换
Advances in Liquid Biopsy Biomarkers for Monitoring and Evaluating the Therapeutic Response of Breast Cancer
收藏切换
Zhihua LIa, Yuan LIa, Guobin QIUb, Xixiao YANGa, *
Pharmacy Today | 2026, 36(6) : 467 - 473
Less
收藏切换
Pharmacy Today | 2026, 36(6): 467-473
Advances in Liquid Biopsy Biomarkers for Monitoring and Evaluating the Therapeutic Response of Breast Cancer
Full
Zhihua LIa, Yuan LIa, Guobin QIUb, Xixiao YANGa, *
Affiliations
  • a.Department of Pharmacy, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong 518100, China
  • b.Department of Thyroid and Breast Surgery, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong 518100, China
Published: 2026-06-25 doi: 10.12048/j.issn.1674-229X.2026.06.011
Outline
收藏切换

Breast cancer is a malignant tumor with a high incidence rate among women, and its high heterogeneity leads to great differences in therapeutic responses to treatment regimens. Early efficacy assessment of breast cancer therapy can help identify ineffective treatment regimens as soon as possible, allowing for timely adjustments in treatment strategies. This effectively avoids treatment delays and toxic damage from ineffective regimens, thereby improving patients' therapeutic benefits. Currently, the evaluation of therapeutic efficacy for breast cancer primarily relies on imaging methods to monitor changes in tumor size before and after treatment. However, monitoring such changes often requires a lengthy evaluation period, making it difficult to meet the clinical need for early efficacy assessment. Liquid biopsy is a minimally invasive detection method that analyzes tumor-derived biomarkers in body fluids, such as circulating tumor cells, circulating tumor DNA, circulating tumor microRNA, extracellular vesicles, proteins, and metabolites, to obtain pathophysiology-related information of tumors. This enables real-time monitoring of tumor status and progression, demonstrating broad application prospects in the monitoring and evaluation of tumor treatment efficacy. This review will systematically summarize the advances in liquid biopsy biomarkers for the monitoring and evaluation of breast cancer treatment efficacy, while also analyzing and discussing the challenges in their clinical translation and potential future developments in this field.

breast cancer  /  therapeutic efficacy evaluation  /  liquid biopsy  /  biomarkers  /  precision therapy
李志华, 李园, 丘国彬, 杨西晓. 乳腺癌治疗疗效监测评估的液体活检生物标志物研究进展. 今日药学, 2026 , 36 (6) : 467 -473 . DOI: 10.12048/j.issn.1674-229X.2026.06.011
Zhihua LI, Yuan LI, Guobin QIU, Xixiao YANG. Advances in Liquid Biopsy Biomarkers for Monitoring and Evaluating the Therapeutic Response of Breast Cancer[J]. Pharmacy Today, 2026 , 36 (6) : 467 -473 . DOI: 10.12048/j.issn.1674-229X.2026.06.011
Year 2026 volume 36 Issue 6
154
32
Cite this Article
BibTeX
Article Info
doi: 10.12048/j.issn.1674-229X.2026.06.011
  • Receive Date:2025-10-21
  • Online Date:2026-09-23
  • Published:2026-06-25
Article Data
Affiliations
History
  • Received:2025-10-21
Funding
Affiliations
    a.Department of Pharmacy, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong 518100, China
    b.Department of Thyroid and Breast Surgery, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong 518100, China
References
Share
https://castjournals.cast.org.cn/joweb/jryx/EN/10.12048/j.issn.1674-229X.2026.06.011
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT